Opko snags Ophthalmic Technologies

Article

Opko Health has entered into an agreement to acquire the Canadian company, Ophthalmic Technologies.

Opko Health has entered into an agreement to acquire the Canadian company, Ophthalmic Technologies.

Ophthalmic Technologies markets a complete line of ophthalmic ultrasound and imaging products and its SLO/OCT system provides a flexible platform for processing a wide variety of diagnostic tests.

According to the terms of the agreement, Opko has purchased one-third of the outstanding common shares of the company and has received an exclusive option to purchase the remaining shares over a period of six months.

Opko has also hired Steven Verdooner as Executive Vice President of Instrumentation, a newly created position.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.